news Antibodies and remdesivir used to treat Marburg virus in rhesus macaques 26 March 2021 | By Victoria Rees (Drug Target Review) The combination of mAbs and remdesivir induced an 80 percent protection rate against Marburg virus in rhesus macaques, according to a new study.
news New small molecules can prevent filovirus infection in cells 9 February 2021 | By Victoria Rees (Drug Target Review) Through a series of experiments, researchers have identified small drug molecules that can inhibit filoviruses such as Ebola and Marburg.
news Experiments with Marburg virus reveal novel antibody protective mechanisms 22 April 2020 | By Hannah Balfour (Drug Target Review) Researchers discovered the monoclonal antibodies of a convalescent Marburg infection patient bound to the glycoprotein and combatted infection in two novel ways.
news TSRI scientists discover workings of first promising Marburg virus treatment 11 January 2018 | By Drug Target Review Scientists at The Scripps Research Institute (TSRI) have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus.